Expand VERA Menu
VERA MENU

VERA Latest Press Releases

-- December 9, 2025 --

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock Globe Newswire 8:57 PM

-- December 8, 2025 --

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock Globe Newswire 4:01 PM

-- December 5, 2025 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 26, 2025 --

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors Globe Newswire 4:05 PM

-- November 24, 2025 --

Vera Therapeutics to Participate at Upcoming Investor Conferences Globe Newswire 7:25 AM

-- November 10, 2025 --

Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit Globe Newswire 7:29 AM

-- November 7, 2025 --

Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy Globe Newswire 6:27 PM
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 6, 2025 --

Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine Globe Newswire 9:51 AM

-- November 5, 2025 --

Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results Globe Newswire 7:29 AM

-- October 22, 2025 --

Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET Globe Newswire 8:00 AM

-- October 17, 2025 --

Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025 Globe Newswire 9:12 AM

-- October 10, 2025 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- September 5, 2025 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 26, 2025 --

Vera Therapeutics to Participate at Upcoming Investor Conferences Globe Newswire 4:05 PM

-- August 8, 2025 --

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 5, 2025 --

Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes